Is Europe Taking Too Long to Adopt TMS for Major Depression?
Repetitive transcranial magnetic stimulation has been approved for more than a decade in the US, but Europe still needs clear guidelines.
Stay updated with breaking news from Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repetitive transcranial magnetic stimulation has been approved for more than a decade in the US, but Europe still needs clear guidelines.
/PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs,...
Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of...
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic : Rashtra News #Moderna #CEO #Stephane #Bancel #sold #million #company #stock #pandemic Moderna CEO Stephane BancelSteven Ferdman | Getty ImagesModerna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the coronavirus pandemic — averaging
/PRNewswire/ -- Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical...